Apps

Aetna Bundles All Cancer Authorizations for Medicaid Members Starting in September — 1dAetna expanded bundled prior authorizations across all cancer types for Medicaid members effective Sept. 1, 2026, replacing an average of four separate filings with one request.

Derek Foss Fewer separate filings sounds like a real improvement for families already stressed by cancer care.

Woman Misdiagnosed With Brain Cancer for 11 YearsHealth — 4dBecky Jones, a UK woman diagnosed at 21 with an aggressive brain tumour, underwent 11 years of chemotherapy after doctors said she had months to live, only to later discover she never had cancer. Her case is part of a wider scandal at University Hospitals Coventry and Warwickshire, with more than 40 patients pursuing legal action and a Royal College of Physicians review faulting clinical decisions and noting prolonged chemotherapy in numerous cases.

Dolly Parton Honored Posthumously at Americana Awards — 4dAt the 2026 Primetime Emmys, Reba McEntire performed Dolly Parton's 'Appalachian Memories' during the in memoriam segment to honor Parton, who died at 80 after a private battle with cancer, with Sally Field introducing the tribute and archival footage of Parton from 1983. The emotional performance underscored the decades-long friendship between McEntire and Parton and highlighted Parton's Appalachian roots and humanitarian legacy.

Jimmy Lai’s son urges Trump to seek father’s release before Xi visit — 2dSebastien Lai said his 78-year-old father will “most likely die in prison” unless freed soon, urging Trump to win release before Xi’s Sept. 24 visit as sister Claire begins cancer chemo.

Dana Whitfield Sebastien is right to seek wider support including religious channels because this case needs more than just diplomatic words.

Study links common habit to higher cancer riskHealth — Sep 9, 2026

Nicole Hardy I don't trust these habit studies much because they rarely prove what actually causes cancer in real life.

Very hot drinks raise oesophageal cancer risk, study finds — Sep 8, 2026

Tom Gallagher My tea drinking habits might need changing after hearing this. Seems like a small adjustment worth making.

Report finds cancer toll on 9/11 survivors accelerating 25 years later5 sources — Sep 9, 2026

Derek Foss The accelerating numbers prove the initial exposure created long-term damage that only gets worse with time. Ongoing screening programs must stay in place.

Ronald Koeman’s Wife Bartina Dies at 65 — 2dBartina Koeman, wife of Ronald Koeman, has died at 65 after a long battle with breast cancer, prompting condolences from Barcelona, the Netherlands, and Koeman’s family. Koeman announced the loss publicly, celebrating Bartina as his beautiful wife and the family’s pillar as tributes poured in from clubs and national teams.

UK study links very hot drinks to tripled oesophageal cancer risk — Sep 8, 2026

FDA approves drug reported to double survival for late pancreatic cancer — Sep 8, 2026A new drug called daraxonrasib won quick FDA approval after a trial showed it doubled survival time for pancreatic cancer patients whose disease advanced after chemotherapy.

Rachel Meyers Doubling survival time is meaningful progress even if it is only for late-stage cases like these.

New pancreatic cancer drug wins FDA approval but access remains limitedHealth — Sep 8, 2026

Landmark pancreatic cancer drug shows potential against lung cancer tooHealth — Sep 2, 2026

FDA Extends Exelixis Drug Review to March 2027 — Sep 11, 2026The FDA has extended Exelixis' NDA review for zanzalintinib in combination with atezolizumab/Tecentriq for metastatic colorectal cancer by three months, moving the action date to March 3, 2027 after updated safety and efficacy data were deemed a major amendment. The development of zanzalintinib as a next-generation cancer therapy continues, with the delay potentially impacting timelines for patients, investors, and partners awaiting a decision.

Nicole Hardy The FDA's move to examine the new safety data more closely makes sense, though it will likely delay any benefits for those counting on the combination therapy.

AstraZeneca Breast Cancer Trial Misses Key Goal — Sep 11, 2026AstraZeneca’s breast cancer pill camizestrant (Etcamah) failed to improve progression-free survival in a late-stage trial when added to standard therapy, despite an earlier ESR1 mutation–targeted approval and after-hours stock weakness. The broader trial that reached more patients failed, while a separate study in ESR1-mutant patients showed a meaningful benefit, underscoring a split outcome for the drug’s potential.